Refine
Year of publication
- 2012 (291) (remove)
Document Type
- Article (127)
- Conference Proceeding (81)
- Part of a Book (35)
- Book (26)
- Patent (11)
- Doctoral Thesis (6)
- Report (3)
- Habilitation (1)
- Other (1)
Has Fulltext
- no (291) (remove)
Keywords
- (Bio)degradation (1)
- 3. EU Legislativpaket (1)
- 802.15.4 (1)
- Acceleration (1)
- Afterload (1)
- Alginate beads (1)
- Anastomotic leakage (1)
- Autolysis (1)
- Avalanche (1)
- Bank-issued Warrants (1)
- Bluetooth (1)
- Borehole heat exchanger (1)
- Calorimetric gas sensor (1)
- Cell permeability (1)
- CellDrum (1)
- Cellular force (1)
- Central receiver system (1)
- Chemical imaging sensor (1)
- Circular Dichroism (1)
- Cloud Computing (1)
Institute
- Fachbereich Medizintechnik und Technomathematik (70)
- Fachbereich Wirtschaftswissenschaften (42)
- Fachbereich Bauingenieurwesen (30)
- INB - Institut für Nano- und Biotechnologien (30)
- Fachbereich Elektrotechnik und Informationstechnik (29)
- IfB - Institut für Bioengineering (29)
- Fachbereich Maschinenbau und Mechatronik (27)
- Fachbereich Chemie und Biotechnologie (26)
- Fachbereich Energietechnik (20)
- Solar-Institut Jülich (15)
- Fachbereich Luft- und Raumfahrttechnik (12)
- Fachbereich Gestaltung (9)
- Fachbereich Architektur (6)
- Sonstiges (3)
- FH Aachen (1)
- Freshman Institute (1)
- IBB - Institut für Baustoffe und Baukonstruktionen (1)
- Nowum-Energy (1)
In this study we observed courses of micturition symptoms and differentiated degrees of symptoms for each point in time while also considering the impact of bothersomeness. Our data show that not only significantly more patients who have undergone BT suffer from OAB than those who have undergone RP, but also that those affected show significantly higher values for severity of OAB symptoms throughout the whole observation period of 36 months. Our data analysis further shows that variability of OAB symptoms as well as fluctuation of severity of OAB symptoms vary to a significantly higher degree after BT than after RP. Looking only at mean figures at a given point in time clearly underestimates the underlying problem. This fact is not reflected in the literature.
Partikelmesstechnik
(2012)
Der Schutz von Produkten vor der Kontamination durch Partikel gilt als eine zentrale Aufgabe der Reinraumtechnik. Da es dabei um Kontaminationseffekte weit unterhalb der visuellen Wahrnehmbarkeit geht, braucht es leistungsfähige Verfahren, um die Messgröße „Partikelkontamination“ über den gesamten Bereich, den Anwender fordern, präzise zu bestimmen. Neben der Partikelhäufigkeit ist dabei die Größe der Partikel, die sowohl das Transportverhalten wie auch die mögliche Wirkung auf das Produkt beeinflusst, von entscheidender Bedeutung. Ferner kann es für die Ermittlung von Kontaminationsquellen von Interesse sein, die Form und die chemische Natur der Partikel zu bestimmen (z. B. textile Fasern, Metallabrieb, flüssige Tröpfchen). Die Partikelhäufigkeit wird üblicherweise als Konzentration, d. h. bezogen auf das analysierte Gasvolumen angegeben. Bei den in reinen Technologien üblichen niedrigen Konzentrationen dient als Häufigkeitsmaß die Partikelanzahlkonzentration, also die Partikelanzahl pro Volumeneinheit des Trägermediums.
Many applications in computational science and engineering require the computation of eigenvalues and vectors of dense symmetric or Hermitian matrices. For example, in DFT (density functional theory) calculations on modern supercomputers 10% to 30% of the eigenvalues and eigenvectors of huge dense matrices have to be calculated. Therefore, performance and parallel scaling of the used eigensolvers is of upmost interest. In this article different routines of the linear algebra packages ScaLAPACK and Elemental for parallel solution of the symmetric eigenvalue problem are compared concerning their performance on the BlueGene/P supercomputer. Parameters for performance optimization are adjusted for the different data distribution methods used in the two libraries. It is found that for all test cases the new library Elemental which uses a two-dimensional element by element distribution of the matrices to the processors shows better performance than the old ScaLAPACK library which uses a block-cyclic distribution.
Persistent infection with high-risk human papillomaviruses (hrHPV) can result in the formation of anogenital cancers. As hrHPV proteins E6 and E7 are required for cancer initiation and maintenance, they are ideal targets for immunotherapeutic interventions. Previously, we have described the development of DNA vaccines for the induction of HPV16 E6 and E7 specific T cell immunity. These vaccines consist of ‘gene-shuffled’ (SH) versions of HPV16 E6 and E7 that were fused to Tetanus Toxin Fragment C domain 1 (TTFC) and were named TTFC-E6SH and TTFC-E7SH. Gene-shuffling was performed to avoid the risk of inducing malignant transformation at the vaccination site. Here, we describe the preclinical safety evaluation of these candidate vaccines by analysis of their transforming capacity in vitro using established murine fibroblasts (NIH 3T3 cells) and primary human foreskin keratinocytes (HFKs). We demonstrate that neither ectopic expression of TTFC-E6SH and TTFC-E7SH alone or in combination enabled NIH 3T3 cells to form colonies in soft agar. In contrast, expression of HPV16 E6WT and E7WT alone or in combination resulted in effective transformation. Similarly, retroviral transduction of HFKs from three independent donors with both TTFC-E6SH and TTFC-E7SH alone or in combination did not show any signs of immortalization. In contrast, the combined expression of E6WT and E7WT induced immortalization in HFKs from all donors. Based on these results we consider it justified to proceed to clinical evaluation of DNA vaccines encoding TTFC-E6SH and TTFC-E7SH in patients with HPV16 associated (pre)malignancies.